{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:53:26Z","timestamp":1779893606121,"version":"3.53.1"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00079","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T04:26:51Z","timestamp":1549340811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?"],"prefix":"10.3389","volume":"10","author":[{"given":"Anna","family":"Grohov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"D\u00e1\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"\u0160p\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Palov\u00e1-Jel\u00ednkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2337\/db16-0806","article-title":"Differentiation of diabetes by pathophysiology, natural history, and prognosis","volume":"66","author":"Skyler","year":"2017","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.imbio.2017.03.001","article-title":"T cell metabolism in metabolic disease-associated autoimmunity","volume":"222","author":"Amersfoort","year":"2017","journal-title":"Immunobiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/db14-0803","article-title":"Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes","volume":"64","author":"Yip","year":"2015","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2337\/dc14-0316","article-title":"Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS)","volume":"37","author":"Menart-Houtermans","year":"2014"},{"key":"B9","first-page":"60","article-title":"Effects and mechanism of hyperglycemia on development and maturation and immune function of human monocyte derived dendritic cells","volume":"34","author":"Yao","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11596-014-1224-1","article-title":"Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response","volume":"34","author":"Han","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cellsig.2013.11.031","article-title":"High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression","volume":"26","author":"Kumar","year":"2014","journal-title":"Cell Signal"},{"key":"B12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4049\/jimmunol.1600676","article-title":"Tolerogenic dendritic cells from poorly compensated type 1 diabetes patients have decreased ability to induce stable antigen-specific T cell hyporesponsiveness and generation of suppressive regulatory T cells","volume":"198","author":"D\u00e1\u0148ov\u00e1","year":"2017","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrendo.2014.2","article-title":"Immune modulation in humans: implications for type 1 diabetes mellitus","volume":"10","author":"Roep","year":"2014","journal-title":"Nat Rev Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db10-1643","article-title":"Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death","volume":"60","author":"Arif","year":"2011","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2014.06.009","article-title":"Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients","volume":"154","author":"Segovia-Gamboa","year":"2014","journal-title":"Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/db13-0886","article-title":"It's time to bring dendritic cell therapy to type 1 diabetes","volume":"63","author":"Creusot","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2018_195","article-title":"Stem cell therapy and type 1 diabetes mellitus: treatment strategies and future perspectives","author":"Farooq","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12967-016-1090-7","article-title":"Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes","volume":"14","author":"Marek-Trzonkowska","year":"2016","journal-title":"J Transl Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2337\/dc11-1406","article-title":"Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide","volume":"34","author":"Haller","year":"2011","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.2337\/dc09-0967","article-title":"Autologous umbilical cord blood transfusion in very young children with type 1 diabetes","volume":"32","author":"Haller","year":"2009","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1741-7015-10-3","article-title":"Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.ebiom.2015.11.003","article-title":"Modulation of autoimmune T-cell memory by stem cell educator therapy: phase 1\/2 clinical trial","volume":"2","author":"Delgado","year":"2015","journal-title":"EBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10238-013-0266-1","article-title":"Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells","volume":"15","author":"Dave","year":"2015","journal-title":"Clin Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0168-8227(09)70002-6","article-title":"Hypothesis: the \u201cmetabolic memory\u201d, the new challenge of diabetes","volume":"86","author":"Ceriello","year":"2009","journal-title":"Diabetes Res Clin Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"137919","DOI":"10.1155\/2014\/137919","article-title":"Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress","volume":"2014","author":"Yan","year":"2014","journal-title":"J Diabetes Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.3399\/bjgp13X663244","article-title":"Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria","volume":"63","author":"Gholap","year":"2013","journal-title":"Br J Gen Pract."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","article-title":"Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications","volume":"1243","author":"Ramasamy","year":"2011","journal-title":"Ann N Y Acad Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00125-007-0684-2","article-title":"Reactive oxygen species mediate a cellular \u2018memory' of high glucose stress signalling","volume":"50","author":"Ihnat","year":"2007","journal-title":"Diabetologia"},{"key":"B38","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","article-title":"Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways","volume":"274","author":"Huttunen","year":"1999","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3892\/ijmm.2017.2991","article-title":"TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic beta-cells through the protein kinase C beta pathway","volume":"40","author":"Wang","year":"2017","journal-title":"Int J Mol Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00441-012-1508-3","article-title":"Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19(+), CD3 (+) and Mac-1 (+) cells in lymphoid organs and peritoneal cavity","volume":"351","author":"Brisslert","year":"2013","journal-title":"Cell Tissue Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.4049\/jimmunol.181.6.4272","article-title":"RAGE ligation affects T cell activation and controls T cell differentiation","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2217\/imt.13.50","article-title":"Tolerogenic dendritic cells for Type 1 diabetes","volume":"5","author":"Giannoukakis","year":"2013","journal-title":"Immunotherapy"},{"key":"B46","unstructured":"RoepB Immune Intervention With Tolerogenic Dendritic Cells in Type 1 Diabetes. A Phase 1 Safety Study Called D-sense2015"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2012-03-419747","article-title":"Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells","volume":"120","author":"Everts","year":"2012","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2636701","DOI":"10.1155\/2016\/2636701","article-title":"Metabolism is central to tolerogenic dendritic cell function","volume":"2016","author":"Sim","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/gene.2017.18","article-title":"Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation","volume":"18","author":"Nikolic","year":"2017","journal-title":"Genes Immun."},{"key":"B51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-540-71029-5_12","article-title":"Induction of tolerogenic dendritic cells by vitamin D receptor agonists","volume":"188","author":"Adorini","year":"2009","journal-title":"Handb Exp Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-540-71029-5_11","article-title":"Handjournal of experimental pharmacology \u201cdendritic cells\u201d: the use of dexamethasone in the induction of tolerogenic DCs","author":"van Kooten","year":"2009","journal-title":"Handb Exp Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.4049\/jimmunol.1303316","article-title":"High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells","volume":"194","author":"Malinarich","year":"2015","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.celrep.2015.01.013","article-title":"Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways","volume":"10","author":"Ferreira","year":"2015","journal-title":"Cell Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"14123","DOI":"10.18632\/oncotarget.4234","article-title":"NF-kappaB, p38 MAPK, ERK1\/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol\/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment","volume":"6","author":"D\u00e1\u0148ov\u00e1","year":"2015","journal-title":"Oncotarget"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.it.2011.09.002","article-title":"Intracellular metabolic pathways control immune tolerance","volume":"33","author":"Procaccini","year":"2012","journal-title":"Trends Immunol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.1997.306","article-title":"Effect of glucose on the function of the calcitriol receptor and vitamin D metabolism","volume":"52","author":"Patel","year":"1997","journal-title":"Kidney Int."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e115488","DOI":"10.1371\/journal.pone.0115488","article-title":"Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients","volume":"9","author":"Waschbisch","year":"2014","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/cbin.10827","article-title":"High glucose induces O-GlcNAc glycosylation of the vitamin D receptor (VDR) in THP1 cells and in human macrophages derived from monocytes","volume":"41","author":"Hernandez-Sanchez","year":"2017","journal-title":"Cell Biol Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jsbmb.2014.11.007","article-title":"Calciotrophic hormones and hyperglycemia modulate vitamin D receptor and 25 hydroxyy vitamin D 1-alpha hydroxylase mRNA expression in human vascular smooth muscle cells","volume":"148","author":"Somjen","year":"2015","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bbadis.2016.01.001","article-title":"High glucose and hyperglycemic sera from type 2 diabetic patients impair DC differentiation by inducing ROS and activating Wnt\/beta-catenin and p38 MAPK","volume":"1862","author":"Gilardini Montani","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.4049\/jimmunol.180.5.3166","article-title":"Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes","volume":"180","author":"Mollah","year":"2008","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction\u2013a comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1475-2840-12-80","article-title":"High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells","volume":"12","author":"Lu","year":"2013","journal-title":"Cardiovasc Diabetol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1182\/blood-2010-12-325514","article-title":"Advanced glycation end products of human beta(2) glycoprotein I modulate the maturation and function of DCs","volume":"117","author":"Buttari","year":"2011","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1161\/01.ATV.0000181744.58265.63","article-title":"Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells","volume":"25","author":"Ge","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"574029","DOI":"10.1155\/2013\/574029","article-title":"Resveratrol prevents dendritic cell maturation in response to advanced glycation end products","volume":"2013","author":"Buttari","year":"2013","journal-title":"Oxid Med Cell Longev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.4049\/jimmunol.1401125","article-title":"Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia","volume":"193","author":"Martinez","year":"2014","journal-title":"J Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.2337\/db12-1726","article-title":"Concentration and activity of the soluble form of the interleukin-7 receptor alpha in type 1 diabetes identifies an interplay between hyperglycemia and immune function","volume":"62","author":"Monti","year":"2013","journal-title":"Diabetes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10875-010-9430-5","article-title":"IL-10\/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector\/memory T cells from type 1 diabetic individuals","volume":"30","author":"Torres-Aguilar","year":"2010","journal-title":"J Clin Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1196\/annals.1433.056","article-title":"Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis","volume":"1126","author":"Ramasamy","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpeds.2016.01.066","article-title":"Early formation of serum advanced glycation end-products in children with type 1 diabetes mellitus: relationship with glycemic control","volume":"172","author":"Jaisson","year":"2016","journal-title":"J Pediatr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e34698","DOI":"10.1371\/journal.pone.0034698","article-title":"RAGE expression in human T cells: a link between environmental factors and adaptive immune responses","volume":"7","author":"Akirav","year":"2012","journal-title":"PLoS ONE"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.4049\/jimmunol.1600197","article-title":"The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus","volume":"197","author":"Durning","year":"2016","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","article-title":"Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation","volume":"182","author":"Lal","year":"2009","journal-title":"J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"a007807","DOI":"10.1101\/cshperspect.a007807","article-title":"Breakdown in peripheral tolerance in type 1 diabetes in mice and humans","volume":"2","author":"Jeker","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"B85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MED.0b013e328355a2d5","article-title":"Revisiting regulatory T cells in type 1 diabetes","volume":"19","author":"Zhang","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B86","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko","year":"2007","journal-title":"Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","article-title":"Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes","volume":"54","author":"Brusko","year":"2005","journal-title":"Diabetes"},{"key":"B88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cei.12116","article-title":"CD4(+) CD45RA(-) FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes","volume":"173","author":"Haseda","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.1038\/srep12633","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes\u2013possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","journal-title":"Sci Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2337\/db09-0694","article-title":"Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects","volume":"59","author":"Long","year":"2010","journal-title":"Diabetes"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2017.01.001","article-title":"Generation of human islet-specific regulatory T cells by TCR gene transfer","volume":"79","author":"Hull","year":"2017","journal-title":"J Autoimmun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2249.2007.03475.x","article-title":"Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes","volume":"150","author":"Glisic-Milosavljevic","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e6527","DOI":"10.1371\/journal.pone.0006527","article-title":"Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation","volume":"4","author":"Jailwala","year":"2009","journal-title":"PLoS ONE"},{"key":"B96","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-014-8440-0","article-title":"Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review","volume":"47","author":"Tan","year":"2014","journal-title":"Clin Rev Allergy Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","article-title":"The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements","volume":"44","author":"Procaccini","year":"2016","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2337\/diabetes.54.1.85","article-title":"Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}","volume":"54","author":"Devaraj","year":"2005","journal-title":"Diabetes"},{"key":"B100","first-page":"626","article-title":"Synergy between IL-6 and TGF-beta signaling promotes FOXP3 degradation","volume":"5","author":"Gao","year":"2012","journal-title":"Int J Clin Exp Pathol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/cmi.2011.37","article-title":"Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes","volume":"9","author":"Zhen","year":"2012","journal-title":"Cell Mol Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"645643","DOI":"10.1155\/2011\/645643","article-title":"Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients","volume":"2011","author":"Ryba","year":"2011","journal-title":"Mediators Inflamm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"5463273","DOI":"10.1155\/2017\/5463273","article-title":"Not only glycaemic but also other metabolic factors affect T regulatory cell counts and proinflammatory cytokine levels in women with type 1 diabetes","volume":"2017","author":"Stechova","year":"2017","journal-title":"J Diabetes Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jdiacomp.2014.07.004","article-title":"Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications","volume":"29","author":"El-Samahy","year":"2015","journal-title":"J Diabetes Complications"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1038\/cti.2015.43","article-title":"Treg activation defect in type 1 diabetes: correction with TNFR2 agonism","volume":"5","author":"Okubo","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"194858","DOI":"10.1155\/2013\/194858","article-title":"Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges","volume":"2013","author":"El-Badri","year":"2013","journal-title":"J Nucleic Acids"},{"key":"B107","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12022-015-9362-y","article-title":"Mesenchymal stem cells in the treatment of type 1 diabetes mellitus","volume":"26","author":"Katuchova","year":"2015","journal-title":"Endocr Pathol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"675103","DOI":"10.1155\/2015\/675103","article-title":"Mesenchymal stem cells: rising concerns over their application in treatment of type one diabetes mellitus","volume":"2015","author":"Hashemian","year":"2015","journal-title":"J Diabetes Res."},{"key":"B109","first-page":"82","article-title":"A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus","volume":"7","author":"Cho","year":"2018","journal-title":"Am J Stem Cells"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2017.6832","article-title":"High glucose induces the aging of mesenchymal stem cells via Akt\/mTOR signaling","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1159\/000493828","article-title":"Hyperglycemia altered the fate of cardiac stem cells to adipogenesis through inhibiting the beta-catenin\/TCF-4 pathway","volume":"49","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"5765478","DOI":"10.1155\/2018\/5765478","article-title":"Effects of type 2 diabetic serum on proliferation and osteogenic differentiation of mesenchymal stem cells","volume":"2018","author":"Deng","year":"2018","journal-title":"J Diabetes Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2989076","DOI":"10.1155\/2016\/2989076","article-title":"Effects of oxidative stress on mesenchymal stem cell biology","volume":"2016","author":"Denu","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1089\/scd.2016.0067","article-title":"Receptor for advanced glycation end products-mediated signaling impairs the maintenance of bone marrow mesenchymal stromal cells in diabetic model mice","volume":"25","author":"Aikawa","year":"2016","journal-title":"Stem Cells Dev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbrc.2013.03.018","article-title":"Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells","volume":"433","author":"Zhu","year":"2013","journal-title":"Biochem Biophys Res Commun."},{"key":"B116","first-page":"34","article-title":"Adverse effect of high glucose concentration on stem cell therapy","volume":"7","author":"Saki","year":"2013","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12015-018-9809-x","article-title":"Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use","volume":"14","author":"Kornicka","year":"2018","journal-title":"Stem Cell Rev."},{"key":"B118","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-017-2583-2","article-title":"Hyperglycemia impedes definitive endoderm differentiation of human embryonic stem cells by modulating histone methylation patterns","volume":"368","author":"Chen","year":"2017","journal-title":"Cell Tissue Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/j.dsx.2016.03.016","article-title":"Metabolic memory phenomenon in diabetes mellitus: achieving and perspectives","volume":"10","author":"Berezin","year":"2016","journal-title":"Diabetes Metab Syndr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2337\/db08-1168","article-title":"Expansion of human regulatory T-cells from patients with type 1 diabetes","volume":"58","author":"Putnam","year":"2009","journal-title":"Diabetes"},{"key":"B122","first-page":"1203","article-title":"Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1","volume":"20","author":"Lei","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T11:27:33Z","timestamp":1662895653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":122,"alternative-id":["10.3389\/fimmu.2019.00079"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00079","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"article-number":"79"}}